Brief: Sun Pharma Will Extend Most Favored Nation Pricing To U.S. Medicaid Programs
BRIEF-Sun Pharma Will Extend Most Favored Nation Pricing To U.S. Medicaid Programs Aug 31 (Reuters) - Sun Pharmaceutical Industries Ltd SUN.NS:
SUN PHARMA - PHARMA PARTICIPATES IN WHITE HOUSE CEREMONY ON U.S. MEDICINES PRICING
SUN PHARMA: WILL EXTEND MOST FAVORED NATION (MFN) PRICING TO U.S. MEDICAID PROGRAMS
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com))
Recent news on Sun Pharmaceutical Industries
See all newsROI-US blue wave reshapes Asia's winners and losers: Manishi Raychaudhuri
Brief: Sun Pharma Clarifies Regarding News Report Relating To Company's Assam Facility
Street View: India's Sun Pharma Organon buy, psoriasis drug are risk factors
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses
India orders Sun Pharma to halt eye-care drug production at plant after quality lapses